Renaissance Technologies - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 32 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$67
-34.3%
83,800
-6.4%
0.00%
Q2 2023$102
-45.7%
89,500
-28.5%
0.00%
Q1 2023$188
-26.8%
125,200
-27.4%
0.00%
Q4 2022$257
-99.9%
172,554
-16.2%
0.00%
Q3 2022$319,000
-43.1%
205,800
-16.7%
0.00%
-100.0%
Q2 2022$561,000
+192.2%
247,000
+196.9%
0.00%
Q1 2022$192,00083,1950.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$231,0000.01%
FNY Investment Advisers, LLC 3,500$8,0000.01%
LEO BROKERAGE, LLC 14,845$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 37,900$88,0000.00%
UBS Group AG 13,618$31,0000.00%
RHUMBLINE ADVISERS 16,169$37,0000.00%
Ellevest, Inc. 19$00.00%
TWO SIGMA INVESTMENTS, LP 62,184$144,0000.00%
FMR LLC 179$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,375$24,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders